|
|
|
| From solubility challenges to modified release and pediatric dosage forms, we help sponsors overcome development roadblocks with tailored, scalable solutions. We combine formulation and manufacturing expertise with a sponsor-informed mindset that keeps clinical, regulatory, and commercial goals in focus. At AustinPx, we don’t rely on generic approaches. We collaborate across disciplines to build scientifically sound, strategically aligned formulations. This is where complex challenges meet tailored solutions and where your molecule finds a path that delivers. |
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | A professional of packaging who has weaved through positions in Big Pharma says you should understand any points of leverage you have with a CDMO. However, when leverage is minimal, creating "relationship equity" is the key to win-win relationships for sponsor and provider. After a decade, a well-timed follow up conversation with Dan Marasco. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
Integrating Early Development With Clinical Supply | Webinar | Catalent | In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes. |
|
|
|
|
|
|
PBPK Predictive Modeling Services | Lonza | Early identification of potential absorption risks is critical for rapid and efficient drug development. Learn how our services can de-risk your drug development program. |
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|